{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:04:46Z","timestamp":1775779486880,"version":"3.50.1"},"reference-count":19,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T00:00:00Z","timestamp":1460505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"GlaxoSmithKline (China)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Acne vulgaris affects up to 54% of Chinese adolescents. Combination therapy has become the recommended standard of care for acne.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The aim of this study was to compare the efficacy and safety of clindamycin (1%) and benzoyl peroxide (5%) (<jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BPO<\/jats:styled-content>) gel once daily vs. clindamycin (1%) (<jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content>) monotherapy gel twice daily in Chinese patients with mild to moderate acne.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>1020 patients (aged 12\u201345 years) with mild to moderate acne were randomized (1 : 1); 1016 patients were treated with <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BPO<\/jats:styled-content> (<jats:italic>n<\/jats:italic> = 500) or <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content> (<jats:italic>n<\/jats:italic> = 516) for a 12\u2010week treatment period. Efficacy assessments were performed at baseline, and at weeks 1, 2, 4, 8 and 12; and primarily included change in total lesion count (inflammatory and non\u2010inflammatory lesions), and proportion of patients with a minimum 2\u2010grade improvement in Investigator's Static Global Assessment (<jats:styled-content style=\"fixed-case\">ISGA<\/jats:styled-content>) score. Patient safety and local tolerability were also evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Patients in <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BPO<\/jats:styled-content> group showed a greater per cent reduction in total lesion count compared with patients in <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content> group at week 12 (delta = \u22120.05; 95% <jats:styled-content style=\"fixed-case\">CI<\/jats:styled-content> = \u22120.09, \u22120.02; <jats:italic>P<\/jats:italic> = 0.003); statistically significant reduction in lesion count was noted as early as week 1 and continued through week 12. A greater proportion of patients in <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BPO<\/jats:styled-content> group showed a \u22652\u2010grade improvement in <jats:styled-content style=\"fixed-case\">ISGA<\/jats:styled-content> score at week 12 compared with <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content> group (30.2% vs. 22.7%; <jats:italic>P<\/jats:italic> = 0.018). Overall, the incidence of adverse events (<jats:styled-content style=\"fixed-case\">AE<\/jats:styled-content>s) was higher in the <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BPO<\/jats:styled-content> group (14.4%) than in the <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content> group (7.9%); the most commonly reported events were generally related to application site reactions (erythema, pruritus and swelling). Incidence of drug\u2010related <jats:styled-content style=\"fixed-case\">AE<\/jats:styled-content>s was 8.6% in <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BPO<\/jats:styled-content> group and 1.2% in <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content> group. Both groups showed trends towards reduction in investigator and subject rated local tolerability scores.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">BPO<\/jats:styled-content> gel demonstrated superior efficacy over <jats:styled-content style=\"fixed-case\">CDP<\/jats:styled-content> gel along with acceptable safety and tolerability in Chinese patients with mild to moderate acne.<\/jats:p><\/jats:sec><jats:sec><jats:title>Clinical Trials.gov number: NCT01915732<\/jats:title><\/jats:sec>","DOI":"10.1111\/jdv.13622","type":"journal-article","created":{"date-parts":[[2016,4,13]],"date-time":"2016-04-13T08:57:20Z","timestamp":1460537840000},"page":"1176-1182","source":"Crossref","is-referenced-by-count":7,"title":["A multicentre, randomized, single\u2010blind comparison of topical clindamycin 1%\/benzoyl peroxide 5% once\u2010daily gel versus clindamycin 1% twice\u2010daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients"],"prefix":"10.1111","volume":"30","author":[{"given":"J.H.","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Dermatology Huashan Hospital Fudan University Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.J.","family":"Lu","sequence":"additional","affiliation":[{"name":"Hunan Key Laboratory of Medical Epigenomics Department of Dermatology Second Xiangya Hospital Central South University Changsha China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.H.","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Dermatology Third Xiangya Hospital Central South University Changsha China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Dermatology Southwest Hospital Third Military Medical University Chongqing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.N.","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Dermatology Peking Union Medical College Hospital Chinese Academy of Medical Sciences Peking Union Medical College Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Dermatology The First Affiliated Hospital of Zhejiang University School of Medicine Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Dermatology Changhai Hospital Second Military Medical University Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.Q.","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Dermatology Guangdong General Hospital Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ruijin Hospital Shanghai Jiaotong University School of Medicine Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Dermatology The First Affiliated Hospital of Nanjing Medical University Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.Q.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Second Hospital of Jilin University Changchun China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology Xijing Hospital Fourth Military Medical University Xi'an China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gu","sequence":"additional","affiliation":[{"name":"Institute of Dermatology Chinese Academy of Medical Science and Peking Union Medical College Nanjing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.Q.","family":"Tian","sequence":"additional","affiliation":[{"name":"Shandong Provincial Institute of Dermatology and Venereology Provincial Academy of Medical Science Jinan Shandong China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.L.","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology General Hospital of Guangzhou Military Command of PLA Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.Y.","family":"Xi","sequence":"additional","affiliation":[{"name":"Department of Dermatology Sun Yat\u2010sen Memorial Hospital Guangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology Zhongshan Hospital Fudan University Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology The Second Affiliated Hospital Zhejiang University School of Medicine Hangzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Dermatology Peking University First Hospital Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.T.","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Dermatology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.L.","family":"He","sequence":"additional","affiliation":[{"name":"Department of Dermatology Beijing Chao\u2010Yang Hospital Capital Medical University Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Dermatology Air Force General Hospital Beijing China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.X.","family":"Sheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology Zhongnan Hospital Wuhan University Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Li","sequence":"additional","affiliation":[{"name":"GlaxoSmithKline Pudong Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.G.","family":"Hamedani","sequence":"additional","affiliation":[{"name":"Stiefel, a GlaxoSmithKline Company NC USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,4,13]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1515\/IJAMH.2007.19.4.407"},{"key":"e_1_2_8_3_1","first-page":"24","article-title":"A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies","volume":"3","author":"Davis VC","year":"2010","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04374.x"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb04664.x"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203050-00007"},{"key":"e_1_2_8_7_1","first-page":"281","article-title":"The effect of vehicle formulation on acne medication tolerability","volume":"82","author":"Draelos ZD","year":"2008","journal-title":"Cutis"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02920.x"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03813.x"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(97)70177-4"},{"key":"e_1_2_8_11_1","first-page":"1382","article-title":"Ali\u00f3 S\u00e1enz AB. Safety and efficacy of clindamycin phosphate 1.2%\u2010benzoyl peroxide 3% fixed\u2010dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double\u2010blind, active\u2010 and vehicle\u2010controlled study","volume":"10","author":"Eichenfield LF","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_8_12_1","first-page":"165","article-title":"A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris","volume":"67","author":"Tschen EH","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.06.040"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903401496"},{"key":"e_1_2_8_15_1","first-page":"38","article-title":"New formulations and research support individualized, adherence\u2010promoting topical acne regimens","author":"Bikowski J","year":"2011","journal-title":"Pract Dermatol"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2000.042003134.x"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0536.2002.460205.x"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04509.x"},{"key":"e_1_2_8_19_1","first-page":"1","article-title":"Topical acne therapy: current and advanced options for optimizing adherence","volume":"4","author":"Tan JKL","year":"2009","journal-title":"Skin Therapy Lett Pharm"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200809030-00010"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjdv.13622","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.13622","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdv.13622","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdv.13622","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T13:46:27Z","timestamp":1693921587000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdv.13622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,13]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1111\/jdv.13622"],"URL":"https:\/\/doi.org\/10.1111\/jdv.13622","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,13]]}}}